ChromaDex (CDXC) Announces Retail Distribution of Tru Niagen in Walmart Stores Across the United States
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
ChromaDex (CDXC) Misses Q4 EPS by 1c
March 10, 2021 4:26 PM ESTChromaDex (NASDAQ: CDXC) reported Q4 EPS of ($0.10), $0.01 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $15.4 million versus the consensus estimate of $15.36 million.
Fourth Quarter 2020 and Recent Highlights
Total net sales of $15.4 million, up 18% from $13.1 million in the year ago quarter.Tru Niagen® net sales of $12.3 million, a 21% increase from the year ago quarter.Gross margin of 61.0%, a 400 basis point increase from the year ago quarter.Net loss was ($6.1) million or ($0.10) per share,... More